Manish Grover 의 보수는 Jeena Sikho Lifecare 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	₹692m
Dec 31 2023	n/a	n/a	₹619m
Sep 30 2023	n/a	n/a	₹545m
Jun 30 2023	n/a	n/a	₹442m
Mar 31 2023	₹24m	₹24m	₹338m
Mar 31 2022	₹22m	₹22m	₹112m
Mar 31 2021	₹18m	n/a	₹102m

보상 대 시장: Manish 의 총 보상 ($USD 287.57K )은 Indian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 267.13K ).

보상과 수익: Manish 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Manish Grover (50 yo)

2.9yrs

테뉴어

₹24,000,000

보상

Mr. Manish Grover has been Managing Director of Jeena Sikho Lifecare Limited since August 25, 2021 and its Executive Director since May 29, 2017. He is founder of Jeena Sikho Lifecare Limited. Mr. Grover s...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Manish Grover	Chairman & MD	7.2yrs	₹24.00m	65.57% ₹ 18.9b
Bhavna Grover	Whole Time Director	7.2yrs	₹18.00m	0.20% ₹ 56.2m
Shreya Grover	Non-Executive Director	3.1yrs	데이터 없음	0.0066% ₹ 1.9m
Karan Bindra	Non-Executive Independent Director	2.9yrs	₹144.00k	데이터 없음

5.1yrs

평균 재임 기간

43yo

평균 연령

경험이 풍부한 이사회: JSLL 의 이사회는 경험(평균 재직 기간 5 년)으로 간주됩니다.

Jeena Sikho Lifecare 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Chairman & MD recently sold ₹357m worth of stock

Jeena Sikho Lifecare Limited Announces Resignation of Suraj Prakash Choudhary as Non-Executive and Independent Director

Jeena Sikho Lifecare Limited Announces Resignation of Suraj Prakash Choudhary as Non-Executive and Independent Director

Chairman & MD recently bought ₹7.6m worth of stock

Chairman & MD recently bought ₹27m worth of stock

Chairman & MD recently bought ₹4.5m worth of stock

Recent updates

Chairman & MD recently sold ₹357m worth of stock

Jeena Sikho Lifecare's (NSE:JSLL) Earnings Are Weaker Than They Seem

Full year 2024 earnings released: EPS: ₹27.84 (vs ₹13.80 in FY 2023)

New minor risk - Financial data availability

Jeena Sikho Lifecare Limited Recommends Final Dividend for the Financial Year 2023-2024

Investor sentiment improves as stock rises 17%

Should You Be Adding Jeena Sikho Lifecare (NSE:JSLL) To Your Watchlist Today?

Jeena Sikho Lifecare Limited Announces Resignation of Suraj Prakash Choudhary as Non-Executive and Independent Director

Jeena Sikho Lifecare Limited Announces Resignation of Suraj Prakash Choudhary as Non-Executive and Independent Director

Investor sentiment improves as stock rises 22%

With Jeena Sikho Lifecare Limited (NSE:JSLL) It Looks Like You'll Get What You Pay For

Here's Why We Think Jeena Sikho Lifecare (NSE:JSLL) Is Well Worth Watching

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 26%

Investor sentiment improves as stock rises 46%

Investor sentiment improves as stock rises 21%

New major risk - Share price stability

With EPS Growth And More, Jeena Sikho Lifecare (NSE:JSLL) Makes An Interesting Case

Chairman & MD recently bought ₹7.6m worth of stock

Investor sentiment improves as stock rises 15%

Chairman & MD recently bought ₹27m worth of stock

New minor risk - Dividend sustainability

Full year 2023 earnings released

Jeena Sikho Lifecare Limited to Report Fiscal Year 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 23%

Investor sentiment improves as stock rises 18%

Chairman & MD recently bought ₹4.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Jeena Sikho Lifecare Limited's (NSE:JSLL) Shares Climb 41% But Its Business Is Yet to Catch Up

Less than half of directors are independent

Jeena Sikho Lifecare's (NSE:JSLL) Solid Profits Have Weak Fundamentals

Full year 2022 earnings released: EPS: ₹11.11 (vs ₹10.06 in FY 2021)

Now 25% undervalued after recent price drop

Calculating The Intrinsic Value Of Jeena Sikho Lifecare Limited (NSE:JSLL)

Investor sentiment improved over the past week

Now 22% undervalued

Less than half of directors are independent

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령